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ABSTRACT
EFFECTS OF KNOWLEDGE AND ANXIETY ON WILLINGNESS TO SCREEN
FOR ALZHEIMER’S DISEASE
FEBRUARY 2012
TESSA S. LUNDQUIST, B.A., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Rebecca E. Ready
While the prevalence rates of Alzheimer’s disease (AD) are increasing, the
screening rates for the disease are low. A major barrier to AD screening is older persons’
lack of knowledge about the disease (Ayalon & Arean, 2004). Older adults have anxiety
about AD (Corner & Bond, 2004; Devlin et al., 2007), but less is known about how that
anxiety may affect their screening behavior. The current study measured AD Knowledge
and AD Anxiety and determined how these factors were related to Willingness to Screen
for AD in a sample of midlife and older adults (N = 96, mean age = 62.45, range 55 to
86). It was expected that greater AD Knowledge would be associated with more
Willingness to Screen and that higher AD Anxiety would be associated with less
Willingness. Further, it was hypothesized that AD Anxiety would moderate the
relationship between AD Knowledge and Willingness. AD Knowledge and Trait Anxiety
were not significant predictors of Willingness to Screen, while AD Anxiety was
positively associated with Willingness. AD Anxiety moderated the relationship between
AD Knowledge and Willingness. When individuals had lower AD Anxiety, their
Willingness increased as their AD Knowledge increased. In contrast, for participants with
relatively more AD Anxiety, their Willingness decreased as their AD Knowledge
iv

increased. Understanding how knowledge about AD affects older adult screening
preferences differently based on the amount of anxiety they have about AD will facilitate
development of the most effective interventions to increase awareness about AD and
promote screening.
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CHAPTER I
THE CURRENT STATE OF ALZHEIMER’S DISEASE AND SCREENING
STANDARDS
The United States population is aging at an unprecedented rate and chronic
diseases related to aging are affecting more individuals and families. Alzheimer’s disease
(AD) is one of the most prevalent diseases of aging; an estimated 4.5 million Americans
are currently diagnosed with AD and an estimated 7.7 million are expected to have the
condition by 2030 (Burgener & Berger, 2008). AD causes suffering for families as well as
societal burden, with an annual estimated cost close to 100 billion dollars (Boustani et al.,
2005; Ernst, Hay, Fenn, Tinklenberg, & Yesavage, 1997). AD is generally met with
misunderstanding, fear, and stigma (Devlin, MacAskill, & Stead, 2007).
Despite five FDA approved drugs for AD that can temporarily slow the
progression of symptoms (Alzheimer’s Association, 2008), and the fact that active
management of the disease can improve quality of life for patients and their caregivers
(Connell, Roberts, McLaughlin, & Carpenter, 2009), older adults are reluctant to seek
screening for AD. One major reason that older adults are not screened is a lack of
knowledge about AD and its symptoms (Ayalon & Arean, 2004). Older adults do not
know when or why it is necessary to seek memory evaluations (eg., Devlin et al., 2007;
Galvin, Fu, Nguyan, Glasheen, & Scharff, 2008; Knopman, Donohue, & Gutterman,
2000; VonDras, 2009; Hughes, Tyler, Danner, & Carter, 2009; Werner, 2003b). Thus,
many researchers have suggested implementing programs to raise awareness about AD
and encourage screening by increasing knowledge about the disease and its available
treatments.
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Another barrier to screening may be anxiety about AD, but less is known about
the effect of anxiety on screening behavior. Whereas dementia clearly evokes anxiety and
feelings of dread in older adults (Corner & Bond, 2004; Devlin et al., 2007), the extent to
which those feelings of anxiety may prevent older adults from screening, especially if
they are experiencing memory problems, is not known. The current study will address
this gap in the literature by measuring older adults' anxiety about AD and how it is related
to willingness to screen. In addition, older adults’ knowledge about AD and how it is
related to willingness to screen will be measured. Further, the current study will examine
how anxiety and knowledge may work together in predicting older individuals’
willingness to screen. It is important to investigate not only how knowledge impacts
willingness to screen, but also how anxiety about AD may affect older persons' screening
behaviors. By understanding the impact of knowledge and anxiety on individuals'
willingness to screen for the disease, effective interventions aimed at encouraging
screening can be implemented.

2

CHAPTER II
KNOWLEDGE ABOUT ALZHEIMER’S DISEASE

A. Deficits in Knowledge about Alzheimer’s Disease
As stated above, knowledge about AD affects older individuals’ willingness to
screen for the disease. In a study exploring how certain psychosocial factors are related
to willingness to screen for AD, Galvin et al. (2007) found that knowledge of AD and its
consequences was a significant predictor of willingness to screen. Participants who had
knowledge about dementia and had some idea of the negative impact AD could have on
them and their family members were most likely to express intention to screen for AD.
Similarly, in a study measuring the relationship between knowledge about AD and
willingness to seek help for the disease, Werner (2003b) found that older individuals
having a higher amount of knowledge about AD symptoms were significantly more likely
to express intention to seek professional help for memory problems. However, older
adults often show wide-ranging deficits in knowledge about AD, including poor
knowledge about symptoms, available treatments, course and severity of the disease, and
etiology of AD (Ayalon & Arean, 2004). Older individuals cite deficits in knowledge as
obstacles to seeking assessment for AD. For example, many persons think that all
memory problems are parts of normal aging, that a diagnosis of AD is unnecessary, and
that there is no treatment for AD (Connell et al., 2009). In a study of in-depth interviews
with older persons, Werner (2004) found that older individuals generally thought that
memory problems were an inevitable part of aging. Participants who had knowledge
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deficits about normal aging versus AD symptoms expressed more reluctance about
seeking AD screening.

B. Identifying Memory Changes
Often, older persons are not able to distinguish memory changes due to normal aging
from those that are early signs of AD (Werner, 2004; Knopman et al., 2000). Memory
normally declines with age, with younger persons performing better on memory tasks and
having fewer memory impairments than older persons (Cutler & Hodgson, 1996). Devlin
et al. (2007) conducted qualitative interviews with persons over the age of 50, who will
be at a higher risk for AD as they age. They wanted to explore the views that adults had
about AD to get an idea about how mass media campaigns designed to raise awareness
about dementia could be most effective in the future. Focus groups were conducted with
older persons to explore issues such as knowledge and awareness about AD, perceptions
and beliefs about treatment and support for AD, and issues related to approaching a
primary care doctor with concerns about AD (Devlin et al., 2007). Results indicated that
even though participants had a general awareness about dementia, they had significant
misperceptions about AD. Participants were uncertain about the onset of the disease and
what memory changes were normal for aging, including what memory problems would
be considered severe enough to be symptomatic of AD (Devlin et al., 2007). One
participant said “I forget quite a lot, I don't think it's got anything to do with dementia”
(Devlin et al., 2007, p. 51). The respondents' uncertainty about the onset of AD may have
led to some complacency about memory problems. Several participants reported that
when they experienced memory changes, they would attribute them to normal aging, until
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the symptoms became so bad that they could not avoid them any longer (Devlin et al.,
2007).
A common memory occurrence that would be considered normal for aging would
be forgetting names or appointments, but then being able to remember them later. This
type of memory change is called a retrieval deficit, which means that information that is
stored in memory is not easily accessible (Broder, Herwig, Teipal, & Fast, 2008). Most
older persons would be able to retrieve the memory eventually, while someone with AD
would not. Memory impairment in AD is partly attributed to difficulty with storage and
retrieval of long-term memories, as well as deficits in learning new material (Chang et
al., 2010). Though some types of memory problems are considered normal for aging and
are common in daily life (i.e., retrieval deficits), they are different from memory loss (i.e.,
amnesia) that is symptomatic of AD. Cognitive impairment, a symptom of AD, occurs
when deficits contribute to functional impairment that is sufficient to interfere with
everyday activities (APA, 2000). An example of a functional change associated with
aging would be an individual occasionally needing help adjusting the television or
operating appliances, whereas a sign of AD would be an individual having difficulty
completing daily tasks, such as having difficulty driving to familiar places, or being
unable to manage work duties (Alzheimer's Association, 2008). In AD, functional
impairment is often accompanied by changes in mood, personality, and behavior (Rabin
et al., 2008).
C. Knowledge about Treatment Options
In addition to not being able to identify symptoms of AD, many older individuals
also do not have knowledge about available treatments for AD. To measure what older
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individuals thought were barriers and benefits to seeking a diagnosis of AD, Connell et al.
(2009) administered questionnaires to a sample of adults. All respondents reported
having a family member currently diagnosed with AD. Connell et al. (2009) found that
many participants endorsed screening barriers that were related to treatment, such as
items stating that “so little can be done for people with AD” and “there is no effective
treatment for AD” (Connell et al., 2009, p. 1565).
Werner (2003a) examined barriers associated with older adults’ intention to seek
memory screening when those older adults felt that they were experiencing memory
problems themselves. Barriers included a lack of knowledge about the utility of having a
memory evaluation and a lack of knowledge about treatments for the disease (Werner,
2003a). As discussed previously, Devlin et al. (2007) found that the majority of older
individuals in their sample were unsure of how to distinguish normal memory changes
related to aging from memory symptoms of AD. They also found that participants were
not aware of drug treatments and did not believe that there was any clinical treatment
available for AD, which contributed to participants' perceptions that there was little
benefit to seeking diagnosis (Devlin et al., 2007). When exploring older adults’ intention
to seek memory screening in the presence of memory problems through in-depth
interviews, Werner (2004) found that individuals who believed in the efficacy of AD
treatment expressed a greater intention to seek help for memory problems.

D. Knowledge about Risks and Consequences
When older adults lack knowledge about AD it can affect how susceptible they
think they are to developing the disease, which in turn can affect their willingness to
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screen for it. Galvin et al. (2007) measured intention to screen for AD in a sample of
older adults and found that in addition to having knowledge about the disease in general,
older adults who were able to recognize the consequences of having AD and its negative
effect on them and their family were most likely to express intention to screen (Galvin et
al., 2007). These individuals were able to see a tangible benefit to seeking a diagnosis for
AD through their knowledge about the disease, which outweighed what they thought
were barriers to screening. Perceived susceptibility is greatly affected by knowledge of
the disease in general, as well as the specific knowledge that AD is an illness and not a
part of normal aging (Hughes et al., 2009). Galvin et al. (2007) suggest that more
knowledge about AD leads to more perceived susceptibility and higher perceived benefit
to screening, noting that increasing knowledge in older adults would have a positive
impact on screening behavior.
E. Ethnic Differences in Knowledge
Differences in ethnicity serve as an example of the importance of knowledge in
individuals’ willingness to screen for AD. Ayalon and Arean (2004) found that there were
significant differences in amount of knowledge about AD across four different ethnic
groups of older adults. Even though AD is more prevalent in certain ethnic groups, with
rates being highest in African Americans, these groups are likely to receive diagnoses of
AD at later stages in the disease, which in turn limits their access to early interventions
and available treatments (Ayalon & Arean, 2004; Hughes et al., 2009). Ayalon and Arean
(2004) tested Anglo-Americans, Latino, Asian, and African American older adults and
found that across all groups, the majority of older persons had significant misperceptions
about AD in general, including prevalence, etiology, diagnosis, financial options for
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treatment, and course of the disease. African Americans, Latino, and Asians had
significantly less knowledge about AD than Anglo Americans. Additionally, some
ethnicities held inaccurate beliefs about the etiology of AD. Ayalon and Arean (2004)
found that Asian American and Latino older individuals thought of AD as a contagious
disease and tended to think of memory problems as being caused by the fault of the
individual. Certain ethnic groups’ lack of knowledge about AD could account for their
low detection rates (Ayalon & Arean, 2004). The authors suggest that interventions and
campaigns to increase awareness in minority populations should try to increase
knowledge about AD and inform, for example, that it is not contagious and is not a
normal part of aging (Ayalon & Arean, 2004).
Hughes et al. (2009) found a lack of knowledge about AD in ethnic minority
caregivers of individuals diagnosed with AD. They retrospectively studied experiences of
African Americans and what led them to seek an AD evaluation for their family member
by conducting interviews with caregivers of persons with AD, which included mostly
adult children of AD patients, and a small number of spouses. When asked “Prior to your
family member being diagnosed, how much did you know about Alzheimer's disease?”
most caregivers reported having little knowledge of the disease (Hughes et al., 2009).
One participant said “I first learned about it when I discovered that my mother was
diagnosed with the illness. I really did not know about it, I mean I had heard the word,
the term, but I never did understand it that well until it happened to my mom” (Hughes et
al., 2009, p. 103). Multiple caregivers noted that they were aware of AD as a disease prior
to the diagnosis of their family member, but lacked sufficient knowledge of symptoms,
progression of the disease, and behavioral changes associated with AD (Hughes et al.,
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2009). In fact, almost half of the respondents initially attributed the memory impairment,
loss of intellectual ability, and personality change seen in their family member to normal
aging. Research has shown that African Americans generally have less knowledge about
AD (Ayalon & Arean, 2004) which contributes to the fragmented process and delay to
diagnosis that they often experience (Hughes et al., 2009).
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CHAPTER III
ANXIETY ABOUT ALZHEIMER’S DISEASE
A. Research Exploring Anxiety about AD
As reviewed previously, the amount of knowledge a person has about the
symptoms of AD, the impact of the disease, available treatment options, and the
usefulness of screening are related to individuals' willingness to screen for AD, but the
feelings an individual has about the disease may play a crucial role as well (Corner &
Bond, 2004). Knowledge about AD may not be enough to explain screening behavior.
Minimal research has examined how individuals decide whether and when to seek
memory evaluation once they have identified memory impairment in themselves (Connell
et al., 2009). It is clear that aging may be anxiety provoking for some individuals,
demonstrated, for example, by a reluctance to interact with older persons or refusal to
acknowledge one’s age (Lasher & Faulkender, 1993). AD also evokes anxiety and
feelings of dread in older adults and is associated with fears of losing control, identity,
and dignity (Devlin et al., 2007). When measuring general health anxiety of communitydwelling older adults, Wisocki et al. (1988) found that failing memory was one of their
primary health related worries (as cited in Borgault–Fagnoult & Hadjistavropoulos,
2008).
To begin to look at feelings about AD, Corner and Bond (2004) conducted
qualitative interviews with older adults. The sample included adults over the age of 60
taken from a larger study examining quality of life from the perspective of individuals
diagnosed with dementia and their caregivers. Overall, participants had considerable fear
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and anxiety about developing AD. While there were individuals who could identify
memory problems as possible AD symptoms, some of them reported that anxiety would
inhibit them from seeking a memory evaluation (Corner & Bond, 2004). One participant
was quoted as saying “As soon as you get forgetful you think: 'is it going to happen to
me?' It’s frightening really” (Corner & Bond, 2004, p. 147). Another participant said “the
mere thought of dementia terrifies me...more than any other thing [disease] to die from...”
(Corner & Bond, 2004, p. 148). In fact, the researchers discussed difficulties they had
recruiting for the study, when ten of the twenty-five people initially approached declined
to participate, citing that they would be uncomfortable discussing the topic of AD and
that it would raise painful issues for them. This refusal rate is higher than common for
similar studies, which may itself serve as an example of the fear and anxiety older
individuals have about AD (Corner & Bond, 2004).
B. Stigma and Anxiety
In a study testing the implementation of a screening program for AD, Boustani et
al. (2005) sampled patients, ages 65 and older, from seven primary care clinics and
offered them a brief six item screening questionnaire of memory functioning. The
researchers then offered a full diagnostic evaluation to patients who screened positive for
memory impairment. The offer of further evaluation was made with several incentives;
the patient's physician recommended it, the study staff talked about the importance of the
assessment, and it was offered free of charge, since it was being performed in the primary
care clinic. While only six percent of patients refused the brief six-item screening
questionnaire, half of the patients with positive screening results refused further
diagnostic assessment. This high refusal rate is similar to another study by the same
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authors examining attitudes in residents of continuous care communities towards AD
screening. In this study, 51% of residents would not agree to routine memory screening
(Boustani et al., 2005). The authors note that the high refusal rate in both studies may be
related to a fear that a diagnosis of AD would be a source of stigma and could lead to
emotional harm (Boustani et al., 2005). In fact, Burgener and Berger (2008) write about a
woman who removed her husband from treatment centers for AD and stopped
medications for AD because the “diagnosis of Alzheimer’s was just too stigmatizing for
her and her husband to accept” (Burgener & Berger, 2008, p.36). Stigmatizing attitudes,
which are associated with many chronic diseases, especially those involving mental
health, can make persons more anxious about developing the disease themselves (Jorm,
2000). When designing a campaign to increase awareness about AD, Devlin et al. (2007)
found that the public generally held negative views towards individuals with dementia,
because they tended to think about persons with AD in the later and more severe stages of
the disease.
C. Media Influences
Individuals may form negative attitudes about aging and AD through general
public opinion or media images. Many individuals rely on media as their main source of
information about chronic diseases and mental disorders. A German study found that the
negative depictions of mental diseases in the media led to an increase in negative
attitudes about those disorders (Jorm, 2000). In the case of AD, it is usually the most
despairing features of the disease that are depicted in the media, contributing to
stereotypes about AD and adding to the fear of the disease (Corner & Bond, 2004).
Public figures diagnosed with AD, such as former president Ronald Reagan, are
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presented as experiencing the most debilitating and dreadful aspects of AD. When
conducting in-depth interviews with older individuals to explore their fears about AD,
Corner and Bond (2004) found that many participants were influenced by these negative
media portrayals when thinking about AD. Participants referenced the media images,
focusing on their perceived loss of independence, control, and dignity when expressing
their fear about developing AD.
D. How Anxiety May Effect Screening for AD
1. Avoiding Exposure to AD
While it is clear that some older individuals have significant anxiety about
developing AD (Corner & Bond, 2004; Devlin et al., 2007; Boustani et al., 2005;
Burgener & Berger, 2005), less research has been done on how this anxiety about AD
may affect their willingness to screen for the disease. For some individuals, anxiety
about a disease will be manifested by their avoidance of that disease. As discussed
previously, Corner and Bond (2004) conducted interviews with older adults and found
that they had considerable fear and anxiety about AD. They found that many participants
actively tried to distance themselves from the possibility of having AD. Particularly,
participants who had a family history of the disease purposely did not tell their primary
care doctors about memory loss they were experiencing, reporting that they did not want
their doctor to realize the family connection and evaluate their memory further (Corner &
Bond, 2004). Participants wanted to put off the inevitable as long as possible, and were
frightened of hearing from their doctors that they might have AD. Corner and Bond
(2004) also found that negative feelings about AD came from the experiences of visiting
friends and family members with the disease who were living in a long term care setting.
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These individuals formed negative views of AD from these visits, which eventually lead
them to no longer visit those friends or relatives. Some participants reported consciously
trying not to think about AD, with one participant saying “No, I daren’t let myself think
about it. I just push it to the back of my mind, and try not to think of it” (Corner & Bond,
2004, p. 148). Individuals who avoid receiving or thinking about threatening disease
information report lower levels of anxiety about that disease (VonDras, 2009). Avoiding
someone with the disease or avoiding thinking about the disease lowers its perceived
threat, and when illnesses are perceived as less life threatening, there may be greater
delay in seeking care (VonDras, 2009). In the case of AD, after conducting small focus
groups and interviews with adults over the age of 50, Devlin et al. (2007) found that these
individuals’ anxieties about AD contributed to a feeling of avoidance of the disease,
demonstrated by the participants reporting that they would put off memory evaluation if
they were experiencing memory changes. Participants cited feeling frightened of what
would happen to them once they received a diagnosis of AD, further reporting feeling
shock and dismay at the thought of receiving an AD diagnosis (Devlin et al., 2007).
2. Anxiety Leading to Hyper-vigilance
As discussed above, anxiety may lead to fear and avoidance of AD, which may
lead to less willingness to screen and undergo a memory evaluation. Alternatively,
anxiety may lead to hyper-vigilant symptom checking, to the point where an individual
“symptom-seeks” for memory impairment in themselves (Hodgson & Cutler, 2003;
Cutler & Hodgson, 1996). Individuals who are overly anxious about the possibility of
developing AD may represent a group of older persons who are the “worried well”
(Hodgson & Cutler, 2003). This “anticipatory dementia” involves searching for memory
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changes in oneself and identifying them as warning signals of AD. Werner (2003a) found
that older adults who worried more about developing AD gave themselves worse memory
evaluations than older adults less worried about AD. Suhr and Kinkela (2007) studied the
process by which believing in negative aging stereotypes contributes to heightened health
anxiety about aging. Memory loss is a widespread stereotype associated with aging.
Older individuals internalize the stereotype and thus become more sensitive to memory
changes in themselves, making them more likely to over-estimate the severity of memory
changes that they experience. While the concept of anticipatory dementia is linked to
more concern about the disease and increased symptom seeking for signs of AD, research
has not examined whether that concern leads to more or less willingness to screen, or
other psychological consequences, such as depression in later life (Cutler & Hodgson,
1996). Instead of avoiding screening, these individuals may seek evaluation and
treatment when they have no cause to, which increases risks of misdiagnosis and
initiation of unnecessary medications (Suhr & Kinkela, 2007).
3. An Ideal Level of Anxiety
When designing an effective campaign to raise awareness about AD, Devlin et al.
(2007) found that older persons’ anxiety about the disease did contribute to a feeling of
avoidance of the disease and the desire to put off receiving a diagnosis of AD. They
speculate that providing more information about treatment options and more information
about effective social supports, such as education and counseling, could encourage people
to seek diagnosis earlier (Devlin et al., 2007). There is a large body of research on health
campaigns designed to raise awareness for various diseases. The idea of “fear appeals” is
that fear and anxiety about a disease can be utilized by the campaign to motivate persons
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to engage in disease prevention behavior (Tanner, Hunt, & Eppright, 1991). In the case
of AD, fear appeals may motivate older individuals to approach their doctors and to get
screened if they are experiencing memory problems. If older individuals do have anxiety
about AD that is affecting their health seeking behavior, anxiety will be important to
consider when awareness campaigns are implemented in the future (Devlin et al., 2007).
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CHAPTER IV
KNOWLEDGE, ANXIETY, AND WILLINGNESS TO SCREEN FOR AD
A. Current Study
While it is important to understand how knowledge and anxiety may separately
affect older individuals' willingness to screen for AD, it is also important to consider how
knowledge and anxiety may interact in predicting willingness to screen. There are lags
between the first signs of AD and when individuals recognize those signs as problems,
and also between the first recognition of AD symptoms and professional evaluation
(Knopman et al., 2000). Studies have found that only 26% of older persons who worried
about their memory functioning consulted their physicians about memory problems
(Werner, 2003). These studies indicate that even if an individual is able to identify
memory impairment (e.g. they have adequate knowledge about AD), something is
inhibiting them from getting evaluated. Anxiety may be one factor that keeps older adults
from seeking an evaluation even when they have recognized the symptoms (Corner &
Bond, 2004; Von Dras, 2009).
The current study measured knowledge about AD and determined how it was
related to willingness to screen for AD in a sample of older adults, aged 55 and older.
Anxiety about AD and how anxiety was related to willingness to screen for AD was also
determined. Additionally, the interaction between knowledge and anxiety was measured
to examine how anxiety may have moderated the relationship between knowledge and
willingness to screen.
B. Hypotheses
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Based on previous research (Ayalon & Arean, 2004; Werner, 2003; Galvin et al.,
2008; Connell et al., 2009), it was hypothesized that less knowledge about AD, as
measured by the Alzheimer’s Disease Knowledge Scale, would be related to less
willingness to screen for AD. The relationship between anxiety and willingness to screen
was determined as well. While there are mixed results about anxiety about AD and
health-seeking behavior, there are particularly compelling studies that find that anxiety
about AD is related to avoidance of the disease (Corner & Bond, 2004; VonDras, 2009;
Devlin et al., 2008). Since anxiety about a disease may lead to avoidance of that disease,
it was hypothesized that a higher amount of anxiety would be related to less willingness
to screen for AD. Additionally, as an exploratory hypothesis, it was expected that anxiety
would moderate the relationship between knowledge and willingness to screen. As
discussed, there are delays between first recognition of symptoms of AD and eventual
memory evaluation (Knopman et al., 2003; Werner, 2003). Even though individuals may
have knowledge with which they recognize disease symptoms, they delay in having them
evaluated. Anxiety about AD may be one factor that can explain why adults do not seek
AD screening. Even if someone has enough knowledge about AD to recognize the
symptoms and consequences of the disease, if they have a high amount of anxiety, it may
weaken the positive association between knowledge and willingness to screen. While
higher knowledge about AD is related to more willingness to screen (Galvin et al., 2007;
Werner, 2003b), anxiety about AD may explain why screening rates continue to be low.
C. Significance and Impact
As prevalence rates of AD rise, early detection of AD is becoming more important
to introduce treatment in the beginning stages of the disease. It also affords family
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members an opportunity to understand their loved one’s behavior and make informed
decisions about future care (Connell et al., 2009). When individuals receive a diagnosis
of AD in the early stages, they can opt to begin treatment programs or even participate in
clinical trials where they may be administered experimental treatments not yet available
to the public that can be effective in slowing the progression of AD. Interventions such as
educational materials and workshops about AD increase a sense of control and decrease
distress in caregivers, while drug treatments for AD have been shown to slow the
progression of cognitive decline (Ayalon & Arean, 2004; Connell et al., 2009).
The benefits of early detection and diagnosis of AD have driven an interest in
screening programs for older persons (Ashford et al., 2007; Werner, 2004). Since it is
difficult for patients and primary care doctors to recognize AD, especially when the
symptoms are mild, it is important to have effective routine screening tools that can be
implemented in primary care settings (Ashford et al., 2007). For older adults who do not
have adequate knowledge of AD and its symptoms, it is often not until a triggering event
of memory loss occurs, such as forgetting to turn off the stove, that they will seek a
memory evaluation (Hughes et al., 2009). Behavior changes and functional impairment
associated with AD that remain unrecognized can become dangerous, and safety concerns
can arise. For example, individuals with AD have twice the rate of motor vehicle
accidents than matched individuals without AD (Knopman et al., 2000).
Once knowledge and anxiety about AD are measured and better understood, the
best interventions to promote screening and early detection of AD can be designed. There
is extensive knowledge about effective health campaigns which indicate that it is optimal
to balance “fear-appeals” as motivation while not causing too much heightened anxiety
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about the disease in question (Devlin et al., 2007; Tanner et al., 1991). The amount of
anxiety older persons have about AD will affect how they respond to campaigns trying to
motivate individuals to screen for AD. By measuring two potential barriers to AD
screening (e.g. low knowledge and high anxiety about AD), we will begin to discern
whether one acts as a bigger barrier to AD screening and how they may interact, and
therefore be able to inform the content of future effective interventions and education
campaigns about AD.
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CHAPTER V
METHOD
A. Participants
Participants were 111 community-dwelling, English-speaking healthy older adults
who were aged 55 years and above. Data from fourteen participants were cut from final
analyses because the participants did not provide their age and thus may not have fit one
of the main study criteria of being at least aged 55. One participant's data was excluded
because she reported having a diagnosis of MCI. The final sample size was 96. Data
collection began in July, 2010, and continued until May, 2011. Recruitment involved
fliers posted throughout the community with information about the study and tear-offs
containing contact information of the investigator and web address of the website where
potential participants could complete the survey online. Emails were sent to members of
an existing database of older adults. Finally, emails were sent to family members and
acquaintances, asking them to pass along information about the study to anyone they
knew that fit study criteria and that might be willing to participate. As an incentive,
participants were entered into a raffle with the opportunity to win one of four gift cards to
a popular book store chain.
B. Procedure
Data were collected mainly through an online survey site. One hundred and seven
participants completed the survey electronically via the website. Four participants
completed paper surveys in person after attending a local memory event.
The online survey contained an electronic consent form that participants were
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required to read and sign before participating. If online participants did not complete the
consent page, they could not proceed to the questionnaires and were instead directed to a
web page thanking them for their interest and concluding their participation. If online
participants did complete the consent page, they were directed page by page to the
following questionnaires: Brief Screening Question; Demographic Questionnaire;
Willingness to Screen for Chronic Diseases; AD Knowledge Quiz; AD Anxiety
Questionnaire; State Trait Anxiety Y2; Ten Item Personality Inventory; Willingness to
Screen for AD Questionnaire. Participants who completed the paper version of the survey
were given a packet of survey materials to complete in person. The first questionnaire in
the survey contained two screening questions asking participants if they currently had a
diagnosis of Mild Cognitive Impairment, Alzheimer's disease, or any other type of
dementia. If participants did have a diagnosis of AD, MCI, or dementia, their data were
not included in analyses. There was an information page preceding the questionnaires
with information about what types of questions would be asked and a statement
informing participants that they could feel free to skip any items that they did not want to
answer. The AD Knowledge quiz and AD Anxiety questionnaire were counterbalanced
among surveys, so approximately half of the participants filled out the AD Anxiety
questionnaire before they completed the AD Knowledge quiz, and approximately half of
the participants completed the AD Knowledge quiz before filling out the AD Anxiety
questionnaire. The survey was ordered in this way to detect potential priming effects that
could occur from answering quiz questions about AD before filling out the AD Anxiety
questionnaire. After completing the survey, participants were provided a debriefing form,
as well as an information sheet about AD. All procedures were reviewed and approved by
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the Institutional Review Board at the University of Massachusetts Amherst.
A power analysis of the association between the interaction of AD Knowledge,
AD Anxiety, and Willingness to Screen for AD was conducted to detect an effect size of
.10 of the multiple regression R-squared increase for the moderation effect. Power was
run based on Cohen’s effect sizes with an alpha set at .05. Power analysis revealed a
necessary sample size of 100 subjects. This sample would allow a detection of a small
effect size for the interaction of AD Anxiety and AD Knowledge on Willingness to
Screen for AD with a power of 80 percent.
C. Measures
1. Brief Screening Questionnaire
The screening questionnaire consisted of two questions asking participants if they
currently had a diagnosis of Mild Cognitive Impairment, Alzheimer's disease, or any
other type of dementia. The questionnaire contained instructions that if the participant
answered yes to either question, they should not fill out any more questionnaires and that
their participation would be considered complete. By including this screening
questionnaire, any participants who did not fit study criteria were identified and could be
excluded from data analysis.
2. Demographic Questionnaire
The demographic questionnaire assessed participants’ age, gender, race,
occupation, education, marital status, experience with AD, current and/or past
psychological and/or neurological diagnoses, and memory concerns. The questionnaire
also contained questions about the participant's current health seeking behavior, for
example, whether or not they got regular check-ups with their primary care doctor.
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3. Willingness to Screen for Chronic Diseases
Willingness to screen for chronic diseases that are common for aging, including
AD, was asked at the beginning of the survey, in order to reveal possible differences
between how willing participants are to screen for AD versus other diseases of aging.
Another purpose of this questionnaire was to lead participants away from assuming that
we were mainly interested in willingness to screen for AD. The questionnaire asked
participants to rate on a scale of one to ten, with one being “not at all willing” and ten
being “extremely willing,” how willing they would be to screen for nine common chronic
diseases, such as cancer, heart disease, and AD.
4. AD Knowledge Quiz
Knowledge about AD was assessed using the Alzheimer’s Disease Knowledge
Scale (Carpenter, Balsis, Otilingram, Hanson, & Gatz, 2009). It is a thirty item true/false
quiz about risk factors, assessment and diagnosis, symptoms, course, life impact,
caregiving, and treatment and management of AD. The test can be used to assess
knowledge about AD among laypeople, patients, caregivers, and professionals, with
higher scores indicating more knowledge about AD. There are no subscales; rather a total
knowledge score is derived from this measure. In a sample of 40 adults aged 22-87,
scores on the ADKS ranged from 19 to 30 (M = 24.2, SD = 2.4), there was adequate testretest reliability of 0.81, and there was adequate internal consistency reliability
(Cronbach's alpha = 0.71) (Carpenter et al., 2009).
5. Anxiety Questionnaires
Trait anxiety and AD anxiety were measured. To our knowledge, no questionnaire
currently exists that measures an individual’s amount of anxiety about AD. By including
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measures of trait anxiety as well as having a measure of anxiety about AD, we could
learn if established measures may adequately capture this construct, or if a more specific
measure was needed.
6. AD Anxiety
Items to assess anxiety about AD were constructed for this study. Questions were
asked on a 5-point Likert-type scale, with participants being asked to rate the extent to
which they agree or disagree with each item. In addition to items rated on a scale, there
were two open ended questions asking participants to describe their feelings of anxiety
about developing AD in the future. By including two open-ended items, we were able to
collect potentially interesting descriptive and narrative data on participants’ feelings of
AD anxiety.
7. State Trait Anxiety Inventory Form-Y2 (STAI)
The trait version of the State-Trait Anxiety Inventory Form Y-2 is a widely used
tool to assess clinical anxiety and consists of twenty statements to evaluate how the
participant generally feels. Test-retest reliability in a sample of 25 college students after
104 days was 0.73. The median internal consistency alpha coefficient was 0.90
(Spielberger, 1983).
8. Ten-Item Personality Inventory (TIPI)
The Ten-Item Personality Inventory is a brief measure of the Big-Five personality
dimensions (Gosling et al., 2003). The Big-Five personality framework is a widely used
model of personality traits. The TIPI was developed to be a brief screening measure of
the Big Five. The TIPI was used in the current study in order to measure Neuroticism as
part of the study’s measure of trait anxiety. The TIPI was significantly correlated with the
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BFI, ranging from 0.65 to 0.87 across the personality domains of Extraversion,
Agreeableness, Conscientiousness, Emotional Stability, and Openness to Experience.
Test-retest reliability of the TIPI in a sample of 180 college students after six weeks was
0.72 (Gosling et al., 2003).
9. Willingness to Screen for AD
Participants’ willingness to screen for AD was asked through a variety of
questions. Participants were asked to answer how much they agree or disagree with six
statements on a 5-point Likert-type scale. One item asked participants to rate how willing
they would be to screen for AD if they felt they were experiencing memory problems.
The theory of reasoned action (TRA) indicates that intention is an important predictor of
future behavior (Galvin et al., 2007). Asking older individuals if they would be willing to
undergo AD screening in the presence of memory problems can indicate their likelihood
of future screening behavior. There also was one item asking participants to rate on a
scale from one to ten how willing they would be to undergo a screening test for AD if
they felt they were experiencing memory problems. This latter item was similar to a
study conducted by Werner (2003a), where willingness to screen was measured by one
item asking participants to rate how willing they would be to seek a cognitive status
examination in the next year on a scale of one to ten. By including this item as well as six
others, we constructed a scale measuring willingness to screen for AD. Additionally, the
measure included one item asking participants to rate on a scale of one to ten how likely
they feel it is that they will develop AD at some point in the future.
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CHAPTER VI
RESULTS
A. Preliminary Analyses
1. Participant Characteristics
Data from a total of 96 participants were included in analyses, but there were
some missing data due to participants’ missing items on individual scales. Scale scores
were included in analyses when 20% or fewer items were missing. If participants had
more than 20% of items missing on a given scale, their data were excluded from analyses
using listwise deletion. In the primary analyses, which included regressions to explore the
relationships among AD Knowledge, AD Anxiety, and Willingness to Screen for AD, 81
participants’ data were included. In the regression exploring the relationships among AD
Knowledge, Trait Anxiety, and Willingness to Screen for AD, 85 participants’ data were
included in analyses.
Participants averaged 62.45 years of age with 16 years of education (Table 1).
The majority of participants reported their race as Caucasian (n = 94), one participant
reported their race as Hispanic or Latino, and one participant did not provide their race.
Because of the lack of racial diversity within the sample, no analyses examined
differences in outcomes between races. There were more female (n = 79) than male (n =
17) participants in the current study. Gender differences for Trait Anxiety, AD
Knowledge, Willingness, and AD Anxiety are presented in Table 2. There were no
significant differences between genders among these variables.
2. Development of AD Anxiety Score
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A Principal Components Factor Analysis was conducted on items from the AD
Anxiety questionnaire. On an exploratory basis, two factors were extracted. The factor
matrix revealed that six of the fifteen total items loaded highly (>0.50) on one factor.
Items loading on the first factor were interpretable and had content related to worry about
AD. Items on the second factor had low loadings and content did not converge on a
coherent construct. As a result, a second Principal Components Factor Analysis was
conducted from which one factor was extracted, which accounted for 29.82% of the total
variance. When one factor was extracted, seven items loaded highly (>0.50) on the factor
(Table 3). This factor was labeled ‘AD Anxiety.' The remaining eight items did not hang
together and were excluded from further analyses.
3. Inter-correlations among Anxiety Measures
Correlations were calculated among the three anxiety measures of AD Anxiety,
STAI, and Neuroticism. All of these measures were significantly inter-correlated (AD
Anxiety and Neuroticism, r = 0.29, p < .01; AD Anxiety and STAI, r = 0.33, p < .01;
STAI and Neuroticism, r = 0.55, p < .01). Since the two measures of trait anxiety, STAI
and Neuroticism, were highly correlated with each other and assess the same construct,
STAI and Neuroticism were standardized and averaged to create a 'Trait Anxiety'
variable. AD Anxiety was kept separate and primary analyses were run on both anxiety
measures to detect possible differences between trait anxiety and more specific anxiety
about AD on willingness to screen for AD.
4. Development of Willingness to Screen for AD Scale
A Principal Components Factor Analysis was conducted on items from the
Willingness to Screen for AD questionnaire. One factor was extracted since all of the

28

items were designed to measure the unitary construct of willingness to screen. Five of the
eight total items loaded highly (>.50) on one factor, which accounted for 52.76% of the
total variance (Table 4). Three items did not load highly on the factor, and thus were
excluded from primary analyses. The AD item on the Willingness to Screen for Chronic
Diseases questionnaire was highly correlated with the Willingness to Screen for AD scale
(r = 0.70, p < .01). Due to this significant correlation, further analyses were performed
using the Willingness to Screen for AD scale only.
5. Correlations among Main Outcome Measures
Correlations were run among the main study measures (Table 5). AD Anxiety and
Willingness to Screen were significantly related to each other. AD Knowledge and AD
Anxiety were not significantly correlated with each other, and AD Knowledge and Trait
Anxiety were not significantly correlated with each other. As discussed above, AD
Anxiety and Trait Anxiety were significantly correlated with each other, but were kept
separate in primary analyses. Descriptive statistics for AD Knowledge, Willingness to
Screen for AD, Trait Anxiety, and AD Anxiety are presented in Table 6.
6. Demographic Differences
a. Experience with AD
The variable ‘Experience with AD’ was created based on four demographic items:
(1) whether the participant had a family history of AD in their family, (2) whether they
currently had a family member with AD, (3) whether they had any friends with AD, or (4)
whether they had ever been a caregiver for someone with AD. If the participant answered
‘yes’ to any of the above items, they were included in the ‘Experience with AD’ variable,
so that this variable reflected any participant that had had some type of experience with
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persons with AD. Half of the participants had no experience with AD (n = 45), and half
had experience with AD (n = 45). Six participants were not considered for the
'Experience with AD' variable due to missing data. An independent means t-test revealed
no significant (p < .05) differences between participants with and without experience
with AD on Trait Anxiety, AD Knowledge, Willingness to Screen for AD, or AD Anxiety
(Table 7).
b. Order of Measures
Some participants completed the AD Knowledge quiz before filling out the AD
Anxiety questionnaire (Order 1, n = 61) while other participants filled out the AD
Anxiety questionnaire before completing the AD Knowledge quiz (Order 2, n = 35). An
independent means t-test revealed no significant (p < .05) differences between
participants in the Order 1 group versus those in the Order 2 group on Trait Anxiety, AD
Knowledge, Willingness to Screen for AD, or AD Anxiety (Table 8).
c. Paper versus Online Data Collection
The majority of participants filled out the survey electronically through a survey
website (n = 93), while a small amount filled out the paper version of the survey in
person (n = 3), thus no analyses were performed to compare potential differences
between the different formats of data collection.
B. Primary Analyses
Primary analyses were multiple regressions to test the relationships between AD
Knowledge, Trait Anxiety, AD Anxiety, and Willingness to Screen for AD. To test the
first hypothesis (i.e., that greater knowledge would predict greater willingness to screen),
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a regression analysis was run on the association between AD Knowledge and Willingness
to Screen.
Willingness = a + b1(AD Knowledge) + Error
AD Knowledge alone was not a significant predictor of Willingness to Screen for
AD (B = 0.78, p > .05). The hypothesis that greater knowledge would predict greater
willingness to screen was not supported.
To test the second hypothesis (i.e., that more anxiety would predict less
willingness to screen), a regression analysis was run on the association between AD
Anxiety and Willingness to Screen.
Willingness = a + b1 (Anxiety) + Error
AD Anxiety was a significant predictor of Willingness to Screen for AD (B =
0.25, p < .05). More AD anxiety was associated with more willingness to screen for AD.
In contrast, a regression analysis on the association between Trait Anxiety and
Willingness to Screen indicated that Trait Anxiety was not a significant predictor of
Willingness to Screen for AD (B = -0.06, p > .05). Thus, the second hypothesis that more
anxiety would predict less willingness to screen was partially supported. While trait
anxiety was not significantly associated with willingness to screen, AD anxiety in
particular was significantly related to willingness to screen and it was associated with
more willingness to screen.
The third and most novel hypothesis was that anxiety would moderate the
relationship between AD Knowledge and Willingness to Screen. A moderated multiple
regression determined how AD Knowledge, AD Anxiety, and the interaction between AD
Knowledge and AD Anxiety predicted Willingness to Screen; these factors were entered
in a blocked manner, one after the other (Table 9). AD Knowledge was not significantly
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associated with Willingness to Screen. AD Anxiety was significantly associated with
Willingness to Screen, after controlling for AD Knowledge. The interaction between AD
Knowledge and AD Anxiety was of primary interest and this factor was a significant
predictor of Willingness to Screen, after controlling for AD Knowledge and AD Anxiety.
C. Post-hoc Analyses
To interpret the significant interaction between AD Anxiety and AD Knowledge
scores on Willingness to Screen for AD, a simple slopes analysis was performed
following Aiken and West (1991). Amount of AD Knowledge was regressed separately
on Willingness to Screen for AD for lesser (one standard deviation below the mean), and
greater (one standard deviation above the mean) amounts of AD Anxiety as measured by
total scores on the AD Anxiety scale.
Individuals with greater anxiety about AD showed a significant negative
relationship between AD Knowledge scores and Willingness to Screen for AD, B = -0.73,
p < .01. In contrast, individuals with lesser anxiety about AD showed a significant
positive relationship between AD knowledge and willingness to screen for AD, B = 2.40,
p < .01. This interaction is illustrated in Figure 1.
A moderated multiple regression was performed using Trait Anxiety as the
anxiety measure. These variables were entered in a blocked manner, one after the other
(Table 10). AD Knowledge was not significantly associated with Willingness to Screen.
Trait Anxiety was not significantly associated with Willingness to Screen, after
controlling for AD Knowledge. The interaction between AD Knowledge and Trait
Anxiety was not a significant predictor of Willingness to Screen, after controlling for AD
Knowledge and Trait Anxiety.
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CHAPTER VII
DISCUSSION
A. Summary of Current Study Results
The current study determined how anxiety about AD moderates the association
between knowledge about AD and willingness to screen for AD. Results indicated that
knowledge has differential effects on willingness to screen based on levels of anxiety.
When individuals had less AD anxiety than average, their willingness to screen increased
as their amount of AD knowledge increased. In contrast, for participants with relatively
more anxiety about AD, their willingness to screen decreased as their amount of AD
knowledge increased.
B. Interaction between AD Knowledge and AD Anxiety
A focus of AD research is to increase general awareness and knowledge about
AD to raise screening and early detection rates (e.g. Boustani et al., 2003; Devlin et al.,
2007), but older adults have anxiety about AD (Boustani et al., 2003; Corner & Bond,
2004; Devlin et al., 2007) that may impact how knowledge effects willingness to screen.
Knowledge about AD is multifaceted and includes information about treatment options,
course, and severity of the disease (Ayalon & Arean, 2004). Even though early detection
of AD is shown to be beneficial for patients and caregivers and can lead to effective
active management of the disease (Connell et al., 2009), current drug treatments have
limited efficacy at treating the symptoms of AD and cannot reverse the effects of the
disease. Older adults who know about this information may be inclined to alleviate their
anxiety about AD by avoiding screening for the disease. That is, perhaps individuals with
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greater AD knowledge suspect that a diagnosis of AD would not benefit them in any way,
and are thus less willing to screen. Adult children of parents with AD may represent this
group. Even though adult children have knowledge about AD through their experience
with the disease, they express an avoidance of the disease and report that they would
delay getting a memory evaluation, even if they were experiencing memory problems
(Corner & Bond, 2004). After witnessing AD in a parent, perhaps these adult children
have both greater knowledge and greater anxiety about the disease and do not want to
know if they have it themselves. Future studies should continue to explore the interplay
between knowledge and anxiety in family members of persons with AD and their
healthcare decisions. A possible study could involve measuring knowledge, anxiety, and
willingness to screen in a sample comprised of an equal amount of participants who have
a family member with AD and participants with no family experience with the disease, in
order to compare how knowledge and anxiety about AD effects each of these groups of
participants differently.
The current study indicates that if information is presented to increase knowledge
about AD, then perhaps there should be corresponding information aimed at reducing
anxiety and fear about the disease. Devlin et al. (2007) suggest that providing adults with
information about treatment options and education and counseling about AD could
encourage people to seek an AD diagnosis. For older adults who have less knowledge
about AD, a different type of campaign should be designed. The theory of “fear appeals”
proposes that a certain amount of fear can be utilized to raise anxiety and motivate people
to engage in healthy behavior (Tanner et al., 1991). Results indicate that a campaign
utilizing fear appeals to increase anxiety about AD should not also focus on increasing
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knowledge about the disease, as that may mitigate the effectiveness of the fear appeal. A
campaign designed to increase disease anxiety so that it becomes a motivator may be
most effective only when targeting a group of individuals who do not have prior
experience with and knowledge about AD. Overall, for each individual, there may be
ideal levels of anxiety and knowledge that can be used together to produce the most
effective AD awareness campaigns that will motivate individuals to seek treatment.
C. Main Effect Finding of AD Anxiety
Along with a moderation effect of anxiety on the relationship between AD
knowledge and willingness to screen, there was also a main effect finding that AD
anxiety was significantly associated with willingness to screen for AD, though in the
opposite direction than expected. Without taking AD knowledge into account,
participants who had more anxiety about AD were more willing to screen for the disease.
This result was unexpected given previous findings. For example, Corner and Bond
(2004) found that older adults’ fear and anxiety about AD influenced many of them to
avoid thinking about the possibility of having AD. Similarly, older adults reported that
they would avoid having a memory evaluation because of their fears about the disease
(Devlin et al., 2007). Based on these compelling studies, it was expected that participants
with more AD anxiety would be less willing to screen for AD. One possible explanation
for the unexpected direction of the relationship between anxiety and willingness to screen
could be that the participants in the study conducted by Corner and Bond (2004) had a
mean age of 82, while the current study sample was made up of generally younger older
adults, with a mean age of 62. Corner and Bond (2004) speculate that avoidance of
talking or thinking about AD may increase with age. Perhaps our sample of younger older
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persons represents individuals who are affected by disease anxiety differently than an
older age group of older persons.
It may be that for some individuals, anxiety may be motivating, rather than
contributing to disease avoidance. Individuals who have anxiety about AD may become
hypervigilant about checking for symptoms of the disease (Hodgson & Cutler, 2003;
Cutler & Hodgson, 1996), and may be more willing to undergo evaluation and screening
for AD. Cutler and Hodgson (1996) have conducted extensive research on the concept of
“anticipatory dementia,” in which older adults have anxiety about memory changes and
about developing AD in their lifetime. For these individuals, having some anxiety and
fear about AD influences them to have memory symptoms checked and to seek screening
for AD. Hodgson and Cutler (2003) propose that individuals with a higher level of
education are more likely to have read or heard about AD and its symptoms, and
therefore may be more likely to symptom seek for the disease in themselves. Hodgson
and Cutler (2003) also found that holding higher-prestige occupations was related to
more concern about developing AD in the future, suggesting that the thought of AD is
more threatening to adults who hold cognitively-oriented jobs. The current study sample
was highly educated and had an above average mean income. It is possible that they
represented a group of adults who are more likely to be hyper-vigilant if they have
anxiety about AD, and therefore express more willingness to screen.
D. Exploring the Role of AD Knowledge
Prior studies found that greater knowledge about AD was related to more
willingness to screen for the disease (Galvin et al., 2007; Werner, 2003b; Ayalon &
Arean, 2004: Werner, 2004). In the current study, there was no main effect for AD
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knowledge; it was not significantly associated with willingness to screen for AD. Galvin
et al. (2007) found that older adults with more knowledge about AD had a higher
perceived susceptibility of developing the disease, as well as a higher perceived benefit to
treatment. They report that it was increases in these types of information that contributed
to a higher intention to screen. Coupled with the current study's findings, perhaps it is not
simply knowledge about AD that is related to willingness to screen, but the effect that AD
knowledge has on older adults' perceived vulnerability and benefits of early detection of
AD. Edwards et al. (2000) found that while most respondents in their study knew that
there was no cure for AD, they had significant misconceptions about available services
for the disease. The authors speculate that having knowledge about services and treatment
options increases personal awareness of the disease and enables service and treatment
use. Future studies should further explore the roles that various types of knowledge about
AD play in older adults' thinking about the effects of the disease. Perhaps simply
knowing facts about AD is less important than knowing specific key aspects of the
disease, such as treatment options.
To our knowledge, no previous studies have used the ADKS as the primary
measure of knowledge about AD when measuring the relationship between knowledge
and willingness to screen for AD. Since the ADKS was developed as a general measure
of AD knowledge (Carpenter, 2009), as opposed to a measure of multiple components of
knowledge about AD, it may not have captured the differential effects of specific AD
knowledge on willingness to screen. Future studies should explore the use of a range of
knowledge measures with more specific content, to determine whether the knowledge
measured by some is more related to willingness to screen than in others.
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E. Limitations
Our sample was comprised of mostly Caucasian, highly educated, and middleclass older adults. Additionally, the majority of data were collected through an online
survey site, which requires access to the internet and adequate computer skills. Thus, our
sample may represent a specific cohort of older adults who fit those criteria. It is difficult
to generalize these findings to the general population. Lack of representativeness is a
limitation.
Because of a lack of previous research on anxiety about AD, an AD anxiety
questionnaire was created for this study. Additionally, a questionnaire to measure
willingness to screen for AD was also created for this study. These are limitations since
we could not be sure of these scales' reliability or validity in other samples. We hope our
AD anxiety and willingness measures will continue to be developed and refined in future
research.
F. Conclusion and Future Research
While previous studies have identified that older adults have fear about AD
(Corner & Bond, 2004; Devlin et al., 2007), the current study provided a specific
assessment of AD anxiety. AD anxiety was a significant predictor of willingness to screen
for AD. In addition, this anxiety moderated the effect of knowledge about AD on
willingness to screen for AD. Thus, AD anxiety is an important construct to understand
when developing effective health campaigns and screening programs for AD.
Future studies should further develop and refine the AD Anxiety questionnaire to
facilitate exploration of this construct. AD anxiety represents a specific type of anxiety
that had a different effect than trait anxiety on adults’ screening behavior. More studies
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including measures of anxiety about AD, trait, and state anxiety may reveal more
interesting insight into what influences decisions to screen or not for AD. Given that
adults with more knowledge about AD may be less willing to screen for the disease when
they have more anxiety about it, future studies should further examine the effect of
knowledge on willingness to screen. It is possible that different aspects of knowledge
about AD, such as symptoms, treatment, or personal experience affect older adults’
thoughts and feelings about the disease in different ways. By determining the specific
effects of both knowledge and anxiety about AD, we can understand how these factors
influence older adult's willingness to screen for the disease so that effective healthcare
interventions can be implemented.
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Table 1: Demographic Characteristics of Participants (N = 96)
Characteristic

n

%

Male

17

17.7

Female

79

82.3

White

94

97.9

American Indian,
Alaska Native

1

1

3

3.1

Partial College

20

20.8

College Graduate

23

24

Master’s Degree

32

33.3

Doctoral Degree, MD,
or equivalent

18

18.8

0-15,000

5

5.2

15,000-30,000

14

14.6

30-000-45,000

17

17.7

45,000-60,000

19

19.8

60,000-75,000

7

7.3

Above 75,000

31

32.4

Gender

Race

Education
High School Graduate/
GED

Income (Dollars)
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Table 2: Group Differences for Trait Anxiety, AD Knowledge, Willingness to Screen for
AD, and AD Anxiety Between Genders
Males
Variable

n

M

SD

t

df

1. Trait Anxiety

16

21.16

7.24

-0.57

90

2. AD Knowledge

16

24.38

3.40

1.17

85

3. Willingness

16

30.06

4.77

0.85

90

4. AD Anxiety

16

15.50

4.18

1.30

87

1.Trait Anxiety

76

22.17

6.36

-0.57

90

2. AD Knowledge

71

23.49

2.56

1.17

85

3.Willingness

76

28.71

5.95

0.85

90

4. AD Anxiety

73

13.83

4.75

1.30

87

Females
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Table 3: Factor Loadings From Principal Components Analysis: Communalities,
Eigenvalues, and Percentages of Variance for Items of the AD Anxiety Questionnaire
(continued on to next page)
Factor Loading
1

Item

Communality

1. The older I become the more I worry
about developing AD

.78

.69

2. The thought of AD makes me anxious

.71

.66

3. I avoid thinking about AD because it
worries me

.65

.52

4. I find it hard to stop worrying about AD

.60

.73

5. I'm afraid that my life would have no
meaning if I had AD

.60

.71

6. I worry that if I developed AD I would feel
embarrassed and foolish

.56

.45

7. I worry when I experience small memory
slip-ups

.55

.69

8. I am uncomfortable around individuals with
AD

.45

.79

9. I feel myself get anxious when I am around
individuals with AD

.42

.83

10. Developing AD would ruin my life

.41

.59

11. My heart races when I think about forgetting
who are my friends and family

.37

.72

12. AD is something that people my age should be .34
concerned about

.47

13. I have trouble breathing when I think about AD .33

.61

14. I expect that I would still feel the same about
myself as I do now if I had AD.

-.18

.76

15. I would be able to adapt well if I developed AD -.16

.79
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Eigenvalue

4.47

% of variance

29.82
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Table 4: Factor Loadings from Principal Component Factor Analysis: Communalities,
Eigenvalues, and Percentage of Variance for Items of the Willingness to Screen for
Alzheimer’s Disease Questionnaire
Factor Loading
Item

1
Communality

1. Rate how willing you would be to undergo
a brief screening test for AD if you felt you were
experiencing memory problems

.80

.64

2. I would want to know as early as possible if
I had AD

.89

.76

3. If my primary care doctor was offering free
screenings for AD, I would gladly do one

.87

.76

4. Imagine a hypothetical situation in which you
are suffering from signs of AD, rate how much
you agree with this statement: I would seek
professional help

.80

.64

5. If my doctor told me I was experiencing signs
of AD, I would want to get them evaluated as
soon as possible

.85

.72

6.If I noticed a friend not being able to complete
daily tasks, I would urge them to talk to their
doctors about these memory and functional changes

.31

.09

7. I would like my doctor to give me a screening
test for AD at every check up

.50

.25

8. Please rate how likely you think it is that you will
develop AD at some point in the future.

-.07

.01

Eigenvalue

4.22

% of variance

52.76
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Table 5: Correlations among Trait Anxiety, Willingness to Screen for AD, AD
Knowledge, and AD Anxiety

Variable

Trait Anxiety

Willingness

Willingness

-0.06

AD Knowledge

-0.18

0.14

AD Anxiety

0.39*

0.22**

Note.* p < .05, ** p < .01
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AD Knowledge

-.07

Table 6: Descriptive Statistics of Main Study Variables

Variable

n

M

SD

Trait Anxiety

92

21.99

6.49

AD Knowledge

87

23.66

2.74

17.00

29

0.79

AD Anxiety

89

16.98

5.13

7.00

30

0.82

Willingness to
Screen for AD

92

28.95

5.76

7.00

35

0.87
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Minimum Maximum Cronbach’s
Alpha
12.50
37
0.88

Table 7: Group Differences for Trait Anxiety, AD Knowledge, Willingness to Screen for
AD, and AD Anxiety Between Experience and No Experience with AD

No Experience with AD
Variable

n

M

SD

t

df

1. Trait Anxiety

42

22.23

5.88

0.35

84

2. AD Knowledge

39

23.87

2.75

0.21

80

3. Willingness

41

30.00

4.22

1.75

84

4. AD Anxiety

41

12.86

4.41

-1.91

82

Experience with AD
n

M

SD

t

df

1.Trait Anxiety

44

21.73

7.18

0.35

84

2. AD Knowledge

43

23.74

2.68

0.21

80

3.Willingness

45

27.80

6.95

1.75

84

4. AD Anxiety

43

15.07

4.78

-1.91

82
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Table 8: Group Differences for Trait Anxiety, AD Knowledge, Willingness to Screen for
AD, and AD Anxiety Between Orders

Order 1
Variable

n

M

SD

t

df

1. Trait Anxiety

60

21.62

6.38

-0.76

90

2. AD Knowledge

59

23.81

2.90

0.78

85

3. Willingness

61

28.82

6.13

-0.29

90

4. AD Anxiety

56

14.33

4.62

0.69

87

n

M

SD

t

df

1.Trait Anxiety

32

22.70

6.74

-0.76

90

2. AD Knowledge

28

23.32

2.37

0.78

85

3.Willingness

31

29.19

5.04

-0.29

90

4. AD Anxiety

33

13.74

4.83

0.69

87

Order 2
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Table 9: Willingness to Screen Moderated Regression: Predicting Willingness to Screen
from AD Knowledge and AD Anxiety

Dependent Variable

Independent Variables

B

SE

Beta

t

Block 1

AD Knowledge

0.32

0.21

0.17

1.52

AD Knowledge

0.35

0.21

.018

1.68

AD Anxiety

0.24

0.12

0.22

2.03*

AD Knowledge

0.31

0.20

0.16

1.53

AD Anxiety

0.24

0.11

0.22

2.14*

Knowledge*Anxiety

-1.57 0.57

R2 = 0.03, F(1, 80) = 2.30

Block 2

∆R2 = 0.07, F(2, 79) = 3.27*

Block 3

∆R2 = 0.16, F(3, 78) = 4.84**
* p < .05, ** p < .01
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-0.29 -2.73**

Table 10: Willingness to Screen Moderated Regression: Predicting Willingness to Screen
from AD Knowledge and Trait Anxiety
________________________________________________________________________
Dependent Variable Independent Variables

B

SE

Beta

t

Block 1

0.78

0.60

0.14

1.30

AD Knowledge

0.77

0.61

0.14

1.25

Trait Anxiety

-0.07

0.62

-0.01

-0.11

AD Knowledge

0.73

0.62

0.13

1.18

Trait Anxiety

-0.08

0.62

-0.01

-0.13

Knowledge*Anxiety

0.63

0.73

0.09

0.86

AD Knowledge
R2 = 0.02, F(1, 84) = 1.70

Block 2

∆R2 = 0.00, F(2, 83) = 0.84

Block 3

∆R2 = 0.01, F(3, 82) = 0.81
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Figure 1: Moderated Regression: Predicting Willingness to Screen from AD Knowledge
and AD Anxiety
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APPENDIX A
BRIEF SCREENING QUESTIONNAIRE
Please answer each of the following questions.
1. Do you currently have a diagnosis of Mild Cognitive Impairment?
Yes

No

2. Do you currently have a diagnosis of Alzheimer’s disease, or any other type of
dementia?
Yes

No
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APPENDIX B
DEMOGRAPHIC QUESTIONNAIRE
1. What is your age?

2. What is your gender?
0) M
1) F

3. Are you retired or employed?
0) Retired
1) Employed
If employed, do you work full time or part time?
0) Full time
1) Part time

4. Please circle which of the following best describes your current income:
0) 0-15,000
1) 15,000-30,000
2) 30,000-45,000
3) 45,000-60,000
4) 60,000-75,000
5) Above 75,000
5. What is the highest level of education you have completed? (Please circle one)
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0) Less than 7 years of school (6th grade or less)
1) Junior High School (completed grades 7, 8, or9)
2) Partial High School (completed grade 10 or 11)
3) High School Graduate or GED
4) Partial college
5) College Graduate
6) Master's Degree
7) Doctoral Degree, or MD, or the equivalent

6. Are you Hispanic or Latino?
0) Yes
1) No
2) Don’t know/Not sure

7. Which one of these groups would you say best represents your race?
0) White
1) Black or African American
2) Asian
3) Native Hawaiian or Other Pacific Islander
4) American Indian, Alaska Native
5) Other (specify)
6) Don’t know/Not sure

8. What is your marital status? (Please circle one)
0) Married
1) Widowed
2) Divorced
3) Separated
4) Never married
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5) A member of an unmarried couple

9. Is there a family history of Alzheimer’s disease in your family?
0) Yes
1) No

10. Does anyone in your family currently have Alzheimer’s disease?
0) Yes
1) No

11. Do you have any friends with Alzheimer's disease?
0) Yes
1) No

12. Have you ever been a caregiver for someone with Alzheimer’s disease?
0) Yes
1) No
If yes, please describe the nature of your relationship:

13. Do you have any concerns about your memory functioning at the present time?
0) Yes
1) No
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14. How would you rate your overall health at the present item?
0) Extremely poor
1) Very poor
2) Average
3) Very Good
4) Excellent

15. Have you ever been diagnosed and/or treated with a psychiatric or mental disorder?
0) Yes
1) No

16. Have you ever had a memory evaluation before?
0) Yes
1) No
If yes, please describe where and when:

17. Do you see your doctor for regular check-ups?
0) Yes
1) No
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APPENDIX C
WILLINGNESS TO SCREEN FOR CHRONIC DISEASES

On a scale of 1-10, with 1 being not at all willing and 10 being completely willing, please
rate how willing you would be to screen for the following diseases if you felt you were
experiencing some initial signs of the disease:
Cancer
1

2

3

4

5

6

7

8

9

10

2

3

4

5

6

7

8

9

10

2

3

4

5

6

7

8

9

10

3

4

5

6

7

8

9

10

2

3

4

5

6

7

8

9

10

2

3

4

5

6

7

8

9

10

2

3

4

5

6

7

8

9

10

Heart Disease
1

Diabetes
1

Parkinson's Disease
1

2

Alzheimer's disease
1

Arthritis
1

Osteoporosis
1
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Hypertension
1

2

3

4

5

6

7

8

9

10

2

3

4

5

6

7

8

9

10

Glaucoma
1
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APPENDIX D
KNOWLEDGE QUIZ
Please read each statement carefully and decide whether you think it is true or false, by
circling either “T” if you think the statement is all true or mostly true, and “F” if you
think the statement is all false or mostly false.
1.

People with Alzheimer's disease are particularly prone to depression.

2.

It has been scientifically proven that mental exercise can prevent a person from

getting Alzheimer's disease.
3.

F

T

F

When a person with Alzheimer's disease becomes agitated, a medical examination

might reveal other health problems that caused the agitation.
5.

T

F

F

When people with Alzheimer's disease begin to have difficulty taking care of

themselves, caregivers should take over right away.
7.

T

People with Alzheimer's disease do best with simple, instructions given one step

at a time.
6.

F

After symptoms of Alzheimer's disease appear, the average life expectancy is 6 to

12 years.
4.

T

T

T

F

If a person with Alzheimer's disease becomes alert and agitated at night, a good

strategy is to try to make sure that the person gets plenty of physical activity during the
day. T F
8.

In rare cases, people have recovered from Alzheimer's disease

9.

People whose Alzheimer's disease is not yet severe can benefit from

psychotherapy for depression and anxiety.

T
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F

T

F

10.

If trouble with memory and confused thinking appears suddenly, it is likely due to

Alzheimer's disease.

T

F

11.

Most people with Alzheimer's disease live in nursing homes.

12.

Poor nutrition can make the symptoms of Alzheimer's disease worse.

13.

People in their 30s can have Alzheimer's disease.

14.

A person with Alzheimer's disease becomes increasingly likely to fall down as the

disease gets worse.
15.

T

T

T

F

Once people have Alzheimer's disease, they are no longer capable of making

17.

T

F

Eventually, a person with Alzheimer's disease will need 24-hour supervision.
F
Having high cholesterol may increase a person's risk of developing Alzheimer's

disease. T

F

Tremor or shaking of the hands or arms is a common symptoms in people with

Alzheimer's disease.
20.

F

F

informed decisions about their own care.

19.

T

When people with Alzheimer's disease repeat the same question or story several

16.

18.

F

F

times, it is helpful to remind them that they are repeating themselves.

T

T

T

F

Symptoms of severe depression can be mistaken for symptoms of Alzheimer's

disease. T

F

21.

Alzheimer's disease is one type of dementia.

22.

Trouble handling money or paying bills is a common early symptoms of

Alzheimer's disease.

T

F
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T

F

23.

One symptom that can occur with Alzheimer's disease is believing that other

people are stealing one's things.
24.

T

F

When a person has Alzheimer's disease, using reminder notes is a crutch that can

contribute to decline.

T

F

25.

Prescription drugs that prevent Alzheimer's disease are available.

26.

Having high blood pressure may increase a person's risk of developing

Alzheimer's disease.

T

T

F

F

27.

Genes can only partially account for the development of Alzheimer's disease. T F

28.

It is safe for people with Alzheimer's disease to drive, as long as they have a

companion in the car at all times.

T

F

29.

Alzheimer's disease cannot be cured.

30.

Most people with Alzheimer's disease remember recent events better than things

that happened in the past.

T

F
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T

F

APPENDIX E
ANXIETY ABOUT AD QUESTIONNAIRE
Please read each of the following statements carefully and rate how much you agree with
each statement, ranging from “Strongly disagree” to “Strongly Agree”.
1.

I find it hard to stop worrying about AD

Strongly disagree
2.

Disagree

Don't know

Agree

Strongly Agree

Disagree

Don't know

Agree

Strongly Agree

Disagree

Don't know

Agree

Strongly Agree

Disagree

Don't know

Agree

Strongly Agree

Disagree

Don't know

Agree

Strongly Agree

Disagree

Don't know

Agree

Strongly Agree

I feel myself get anxious when I am around individuals with AD

Strongly disagree
10.

Strongly Agree

I have trouble breathing when I think about AD

Strongly disagree
9.

Agree

AD is something that people my age should be concerned about

Strongly disagree
8.

Don't know

I would be able to adapt well if I developed AD

Strongly disagree
7.

Disagree

I am uncomfortable around individuals with AD

Strongly disagree
6.

Strongly Agree

Developing AD would ruin my life

Strongly disagree
5.

Agree

I worry that if I developed AD, I would feel embarrassed and foolish

Strongly disagree
4.

Don't know

I worry when I experience small memory slip ups

Strongly disagree
3.

Disagree

Disagree

Don't know

Agree

Strongly Agree

My heart races when I think about forgetting who are my friends and family
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Strongly disagree
11.

Disagree

Don't know

Agree

Strongly Agree

Disagree

Don't know

Agree

Strongly Agree

Disagree

Don't know

Agree

Strongly Agree

Agree

Strongly Agree

The thought of AD makes me anxious

Strongly disagree
15.

Strongly Agree

I expect that I would still feel the same about myself as I do now if I had AD

Strongly disagree
14.

Agree

I'm afraid that my life would have no meaning if I had AD

Strongly disagree
13.

Don't know

The older I become, the more I worry about developing AD

Strongly disagree
12.

Disagree

Disagree

Don't know

I avoid thinking about AD because it worries me.

Strongly disagree

Disagree

Don't know

Agree

Strongly Agree

16.

Please describe what comes to mind when you think about AD.

17.

Please describe how you feel about the possibility of developing AD at some

point in the

future.
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APPENDIX F
STATE TRAIT ANXIETY SCALE
Directions:A number of statements which people have used to describe themselves are
given below. Read each statement and then circle the appropriate value to the right of the
statement to indicate how you feel generally on a scale from one to four, with “1”
indicating that you feel that way “Not at all,” “2” that you feel that way “Somewhat,” “3”
that you feel that way “Moderately So” and “4” that you feel that way “Very much So.”
There are no right or wrong answers. Do not spend too much time on any one statement
but give the answer which seems to describe your present feelings best.
1. I feel calm………………………………………. 1

2

3

4

2. I feel secure……………………………………

1

2

3

4

3. I am tense……………………………………… 1

2

3

4

4. I feel strained…………………………………… 1

2

3

4

5. I feel at ease……………………………………... 1

2

3

4

6. I feel upset…………………………………….... 1

2

3

4

7. I am presently worrying over possible misfortunes…1

2

3

4

8. I feel satisfied……………………………….…

1

2

3

4

9. I feel frightened…………………………………. 1

2

3

4

10. I feel comfortable………………………………. 1

2

3

4

11. I feel self-confident…………………………….. 1

2

3

4

12. I feel nervous…………………………………

1

2

3

4

13. I am jittery……………………………………… 1

2

3

4

14. I feel indecisive………………………………… 1

2

3

4

15. I am relaxed…………………………………… 1

2

3

4

16. I feel content…………………………………… 1

2

3

4

17. I am worried……………………………...…….. 1

2

3

4
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18. I feel confused………………………………….. 1

2

3

4

19. I feel steady…………………………………….. 1

2

3

4

20. I feel pleasant……………………………...…… 1

2

3

4
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APPENDIX G
TENTEN-ITEM PERSONALITY INVENTORY
Here are a number of personality traits that may or may not apply to you. Please write a
number next to
each statement to indicate the extent to which you agree or disagree with that statement.
You should rate the extent to which the pair of traits applies to you, even if one
characteristic applies more strongly than the other.

Disagree Disagree Disagree
strongly moderately a little
1

2

Neither agree
nor disagree

3

4

I see myself as:
1.

_____ Extraverted, enthusiastic.

2.

_____ Critical, quarrelsome.

3.

_____ Dependable, self-disciplined.

4.

_____ Anxious, easily upset.

5.

_____ Open to new experiences, complex.

6.

_____ Reserved, quiet.

7.

_____ Sympathetic, warm.

8.

_____ Disorganized, careless.

9.

_____ Calm, emotionally stable.

10._____ Conventional, uncreative.
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Agree
a little
5

Agree
moderately
6

Agree
strongly
7

APPENDIX H
WILLINGNESS TO SCREEN FOR AD
1. On a scale of 1-10, with 1 being not at all willing and 10 being completely
willing, please rate how willing you would be to undergo a brief screening test for
Alzheimer’s disease if you felt you were experiencing memory problems.

1

2

3

4

5

6

7

8

9

10

Please rate how much you agree with the following statements.
2. I would want to know as early as possible if I had AD.
Strongly disagree

3.

Disagree

Don't know

Agree Strongly Agree

If my primary care doctor was offering free screenings for AD, I would gladly do
one
Strongly disagree

Disagree

Don't know

Agree

Strongly Agree

4. For the following question, please imagine a hypothetical situation in which you
were suffering from signs of AD, and then rate how much you agree with the
following statement: I would seek professional help (such as from my primary
care doctor, family physician, psychiatrist, psychologist, neurologist, social
worker).
Strongly disagree

Disagree

Don't know
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Agree

Strongly Agree

5. If I noticed a friend not being able to complete daily tasks and forgetting
appointments and peoples’ names, I would urge them to talk to their doctors about
these memory and functional changes.
Strongly disagree

Disagree

Don't know

Agree

Strongly Agree

6. If my doctor told me I was experiencing signs of Alzheimer's disease, I would
want to get them evaluated as soon as possible.
Strongly disagree

7.

Disagree

Don't know

Agree

Strongly Agree

I would like my doctor to give me a screening test for Alzheimer's disease at
every

check-up.

Strongly disagree

Disagree

Don't know

Agree

Strongly Agree

8. On a scale of 1 to 10, with 1 being extremely unlikely, and 10 being extremely
likely, please rate how likely you think it is that you will develop Alzheimer's
disease at some point in the future.
1

2

3

4

5
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6

7

8

9

10
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